Plans are coming together for G-CAN’s Ninth Annual Symposium, and we are ready to announce a full slate of speakers on a range of gout and crystal-associated disease topics. We also have finalized the topics and leaders for two content-rich workshops: Clinical Study and Trial Design for Hyperuricemia, Gout, and Crystal Deposition Disease, and Calcific Crystalline Arthritis. A full, updated agenda can be found here.
Our meeting will again be in a hybrid format, allowing in-person attendance in La Jolla California, November 7 and 8 or virtually via live streaming. For members who are able to travel, face-to-face sessions will be held at the Estancia Resort and Spa in La Jolla, CA, just 20 minutes from the San Diego International Airport and the San Diego Convention Center.
Those who are not traveling have the option of attending virtually. Presentations will be live streamed and can be watched via a conference website.
The 2023 Symposium will be dedicated to the memory of G-CAN member Dr. Phil Robinson, who passed away earlier this year. In honor of Dr. Robinson and his contributions to G-CAN and the field, a special memorial lecture will be given by G-CAN Vice-President Hyon Choi on the topic of Covid-19 and gout, one of Phil’s special interests.
We will be offering participants several opportunities for networking and social events before and after the general sessions, including a Saturday night banquet followed by our second annual Karaoke party, and an optional brewery tour on Thursday, November 9, after the meeting’s conclusion.
Specifics on registration and hotel accommodations will be available mid-summer. For questions about the upcoming meeting, please contact our Executive Director, Rebecca Hill, RebeccaH@g-can.org.
Now Accepting Early Career Investigator Abstracts
This is a reminder that abstract submissions by Early Career Investigators are now being accepted for the G-CAN 2023 Early Career Investigator Symposium at the Ninth Annual G-CAN Meeting November 7-8.
Submissions are due no later than Sunday, July 30, 2023, at 22:00 USA Pacific Daylight Time. Submission instructions can be found here.
This year’s abstracts will be published in the January 2024 issue of G-CAN’s new journal: Gout, Urate Biology and Crystal Deposition Disease. Authors of submitted abstracts or other works are welcome to consider also sending in full manuscripts of their work to the new G-CAN journal (see below).
G-CAN Launches Inaugural Issue of Journal
We are pleased to remind you that G-CAN has launched the Gout, Urate and Crystal Deposition Disease open access journal with publisher MDPI (https://www.mdpi.com/journal/gucdd).
The March 2023 inaugural issue is now online. The target audience is broad, including people interested in the epidemiology, pathophysiology, imaging, diagnosis, treatment, and outcomes of gout, and hyperuricemia, degenerative and inflammatory calcium crystal arthropathies (including calcium pyrophosphate and basic calcium phosphate crystal deposition disease).
This is the only journal dedicated to the field of gout, urate biology and crystal deposition diseases. The journal ‘s mission is to publish high-quality, original basic science, translational science and clinical science studies, including clinical studies, and also to publish impactful review articles.
The G-CAN Board, and the GUCDD Editors-in-Chief and Editorial Board encourage you to submit original research articles to the new journal. If you have ideas for review articles please contact the Editors-in-Chief (Drs. Tristan Pascart and Tony Merriman).
The next issues will be published in June, September and December of 2023, and bi-monthly issues will be published in 2024. The projected PubMed (retroactive) indexing and impact factor will be in place three years.
Gout Awareness Day: May 22, 2023
On May 22, join the Alliance for Gout Awareness and other related organizations in spreading the word about the disease that affects more than 9 million Americans, its debilitating effects, and how people can manage it. Patient resources and social media tools can be found on the Alliance Website.